Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

25.57
-0.1000-0.39%
Post-market: 25.570.00000.00%19:30 EDT
Volume:728.42K
Turnover:18.45M
Market Cap:2.25B
PE:-5.84
High:26.33
Open:25.47
Low:24.98
Close:25.67
52wk High:47.65
52wk Low:22.00
Shares:88.16M
Float Shares:66.03M
Volume Ratio:0.92
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3763
EPS(LYR):-2.2900
ROE:-80.88%
ROA:-46.18%
PB:4.09
PE(LYR):-11.17

Loading ...

Mineralys Chief Commercial Officer Eric Warren Disposes of $199,900 in Common Shares

Reuters
·
Jul 24

Mineralys CMO David Malcom Rodman Disposes of 416 Common Shares Worth $11,036.48

Reuters
·
Jul 21

Mineralys Therapeutics CMO David Malcom Rodman Disposes of USD 559,234 in Common Shares

Reuters
·
Jul 16

Mineralys CMO David Malcom Rodman Sells 2,171 Common Shares Worth $65,781.30

Reuters
·
Jul 11

Did Index Removal, ENDO 2026 Data and a $150M Raise Just Shift Mineralys Therapeutics' (MLYS) Investment Narrative?

Simply Wall St.
·
Jul 06

Have Insiders Sold Mineralys Therapeutics Shares Recently?

Simply Wall St.
·
Jul 03

Mineralys Therapeutics (MLYS) Left Key Russell Indexes, Is The Stock Still Below Fair Value?

Simply Wall St.
·
Jul 02

Mineralys CCO Eric Warren Disposes of 104,124 Common Shares for $2.7 Million

Reuters
·
Jul 01

Mineralys Therapeutics director Daphne Karydas sells 3,000 shares valued at $75,000

Reuters
·
Jun 18

Mineralys posts ENDO 2026 lorundrostat biomarker presentation on uncontrolled hypertension

Reuters
·
Jun 15

Mineralys Therapeutics presents late-breaking data on lorundrostat

TIPRANKS
·
Jun 15

Mineralys says lorundrostat reduces heart failure risk biomarkers in post hoc analysis of hypertension trials

Reuters
·
Jun 14

Mineralys CMO David Malcom Rodman disposes of common shares worth $203,512.74

Reuters
·
Jun 13

Mineralys Therapeutics to join Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
Jun 09

Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

GlobeNewswire
·
Jun 09

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Mineralys Therapeutics, Inc. (MLYS) and ArriVent BioPharma, Inc. (AVBP)

TIPRANKS
·
Jun 04

Mineralys Therapeutics falls -12.7%

TIPRANKS
·
Jun 03

Mineralys prices offering of 5.66M shares of common stock at $26.50

TIPRANKS
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway

Reuters
·
Jun 03

BUZZ-Mineralys Therapeutics falls after $150 mln stock deal

Reuters
·
Jun 03